BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 34294934)

  • 1. Cholangiocarcinoma.
    Sarcognato S; Sacchi D; Fassan M; Fabris L; Cadamuro M; Zanus G; Cataldo I; Capelli P; Baciorri F; Cacciatore M; Guido M
    Pathologica; 2021 Jun; 113(3):158-169. PubMed ID: 34294934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocarcinoma.
    Brindley PJ; Bachini M; Ilyas SI; Khan SA; Loukas A; Sirica AE; Teh BT; Wongkham S; Gores GJ
    Nat Rev Dis Primers; 2021 Sep; 7(1):65. PubMed ID: 34504109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
    Ilyas SI; Gores GJ
    Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry.
    Izquierdo-Sanchez L; Lamarca A; La Casta A; Buettner S; Utpatel K; Klümpen HJ; Adeva J; Vogel A; Lleo A; Fabris L; Ponz-Sarvise M; Brustia R; Cardinale V; Braconi C; Vidili G; Jamieson NB; Macias RI; Jonas JP; Marzioni M; Hołówko W; Folseraas T; Kupčinskas J; Sparchez Z; Krawczyk M; Krupa Ł; Scripcariu V; Grazi GL; Landa-Magdalena A; Ijzermans JN; Evert K; Erdmann JI; López-López F; Saborowski A; Scheiter A; Santos-Laso A; Carpino G; Andersen JB; Marin JJ; Alvaro D; Bujanda L; Forner A; Valle JW; Koerkamp BG; Banales JM
    J Hepatol; 2022 May; 76(5):1109-1121. PubMed ID: 35167909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of Cholangiocarcinomas.
    Guedj N
    Curr Oncol; 2022 Dec; 30(1):370-380. PubMed ID: 36661679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current diagnostic and management options in perihilar cholangiocarcinoma.
    Rizvi S; Gores GJ
    Digestion; 2014; 89(3):216-24. PubMed ID: 24860985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma: Epidemiology and Imaging-Based Review.
    Kidanemariam S; Gu J; Yoon JH; Challapalli JV; Fruh V; Sax AJ
    R I Med J (2013); 2024 May; 107(5):43-48. PubMed ID: 38687269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholangiocarcinoma.
    Khan AS; Dageforde LA
    Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma: Pathologic and Molecular Classification in the Era of Precision Medicine.
    Gopal P; Robert ME; Zhang X
    Arch Pathol Lab Med; 2024 Mar; 148(3):359-370. PubMed ID: 37327187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinoma.
    Blechacz BR; Gores GJ
    Clin Liver Dis; 2008 Feb; 12(1):131-50, ix. PubMed ID: 18242501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical treatment of cholangiocarcinoma: an updated comprehensive review.
    Elvevi A; Laffusa A; Scaravaglio M; Rossi RE; Longarini R; Stagno AM; Cristoferi L; Ciaccio A; Cortinovis DL; Invernizzi P; Massironi S
    Ann Hepatol; 2022; 27(5):100737. PubMed ID: 35809836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
    Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholangiocarcinoma: risk factors and clinical presentation.
    Gatto M; Alvaro D
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):363-7. PubMed ID: 20496549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging.
    Cholangiocarcinoma Working Group
    Dig Liver Dis; 2020 Nov; 52(11):1282-1293. PubMed ID: 32893173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma: Evolving strategies in management and treatment.
    Bragazzi MC; Venere R; Ribichini E; Covotta F; Cardinale V; Alvaro D
    Dig Liver Dis; 2024 Mar; 56(3):383-393. PubMed ID: 37722960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.